Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 228
Filtrar
1.
Anim Reprod Sci ; 211: 106234, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31785632

RESUMEN

Two experiments evaluated the effects of injectable trace minerals (ITM) administered 11 d before artificial insemination (AI) on body weight (BW), body condition score (BCS), ovarian structures, pregnancy rate, and antioxidant response of Nellore cows. In Experiment 1, 20 multiparous cows were assigned to one of two treatments: subcutaneous injection (6 mL/cow; 11 d before AI) of saline solution or ITM (60, 10, 5, and 15 mg/mL of Zn, Mn, Se and Cu, respectively) and BW, BCS, ovarian structures and blood were evaluated. In Experiment 2, 1,144 multiparous cows were assigned to same treatments described in Experiment 1 and pregnancy rate on d 30 was evaluated. In Experiment 1, ITM did not affect (P ≥  0.23) BW, dominant follicle size, ovulation rate, and plasma concentrations of haptoglobin, ceruloplasmin and progesterone (P4). The ITM treatment tended to increase (P =  0.06) cow BCS and reduce (P ≤  0.06) corpus luteum (CL) diameter and volume. Furthermore, ITM treatment tended to increase (P =  0.06) plasma concentrations of SOD and increased (P =  0.007) GSH-Px compared with saline injection. In Experiment 2, ITM treatment tended (P =  0.06) to increase pregnancy rate of cows with BCS ≤ 5.0 but not cows with BCS > 5.0 (P =  0.99). The ITM treatment did not alter BW, plasma P4, and acute phase response, but enhanced plasma concentrations of antioxidant enzymes, and tended to enhance BCS and pregnancy rates to AI of cows with BCS ≤ 5.0, even though there was a smaller corpus luteum size.


Asunto(s)
Bovinos , Inseminación Artificial/veterinaria , Oligoelementos/administración & dosificación , Animales , Gonadotropina Coriónica/administración & dosificación , Gonadotropina Coriónica/farmacología , Agentes Anticonceptivos Hormonales/administración & dosificación , Agentes Anticonceptivos Hormonales/farmacología , Estradiol/administración & dosificación , Estradiol/análogos & derivados , Estradiol/farmacología , Femenino , Fármacos para la Fertilidad Femenina/administración & dosificación , Fármacos para la Fertilidad Femenina/farmacología , Embarazo , Progesterona/administración & dosificación , Progesterona/farmacología , Reproducción/efectos de los fármacos , Sustancias para el Control de la Reproducción/administración & dosificación , Sustancias para el Control de la Reproducción/farmacología
2.
Artículo en Inglés | MEDLINE | ID: mdl-20074661

RESUMEN

Central regulation of growth hormone (GH) secretion by the GH secretagogue, L-692,585 (585), was determined in Yorkshire barrows (40-45kg BW) with intracerebroventricular (icv) stainless steel cannulas placed by stereotaxic coordinates and indwelling external jugular vein (iv) cannulas for injecting 585 or saline during 3h serial blood sampling. Dose-dependent effects of 585 were determined by icv injections of saline vehicle, 3, 10, and 30microg/kg BW by once daily increment. A switchback study of iv and icv 585 treatment determined central and peripheral regulation of GH secretion by the secretagogue at 30microg/kg BW. When administered icv, 585 increased GH concentration in a dose-dependent manner, with a return to baseline by 60min. GH secretion was attenuated by increased numbers of icv 585 injections (p<0.05); however, it was not affected by increased numbers of iv 585 injections. Icv administration of somatostatin (SRIF) decreased (p<0.05) GH secretion compared with saline-treated controls, and decreased (p<0.05) peak GH response when given in combination with 585 as compared with 585 alone. Porcine galanin (pGAL) modestly increased (p<0.05) GH levels compared with saline controls, but when given icv in combination with 585 peak GH response was lower (p<0.05) compared with 585 alone. Porcine neuropeptide Y (pNPY) administered icv was without effect on GH levels compared with saline controls and decreased (p<0.05) peak GH response when given in combination with 585 as compared with 585 alone. The pharmacological actions by icv administration indicate that the GH secretagogue and neuropeptides act at the level of both porcine pituitary and hypothalamus.


Asunto(s)
Benzazepinas/administración & dosificación , Galanina/administración & dosificación , Hormona del Crecimiento/sangre , Neuropéptido Y/administración & dosificación , Somatostatina/administración & dosificación , Tetrazoles/administración & dosificación , Animales , Catéteres de Permanencia , Hormona Liberadora de Corticotropina , Relación Dosis-Respuesta a Droga , Hidrocortisona/sangre , Inyecciones Intravenosas , Inyecciones Intraventriculares , Masculino , Porcinos
3.
Neuropathol Appl Neurobiol ; 35(5): 462-72, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19490429

RESUMEN

INTRODUCTION: Encephalitis lethargica (EL), an epidemic disease of the early 20th century, has continued to be diagnosed sporadically since that time, including a report of 20 new cases in 2004. Many of the recent case reports state that the primary neuropathology of acute EL consists of inflammatory changes and lesions within the midbrain, basal ganglia and substantia nigra. However, the neuropathology of acute EL cases from the epidemic period was actually much more widespread. METHODS: In order to characterize the neuropathology of acute phase EL, we developed a database of EL pathology based on 112 cases from the years 1915 to 1940, of which most died within 2 weeks of EL onset. RESULTS: Our analysis revealed that cortical damage was prevalent in 75% of the 112 cases; damage to the meninges and brainstem occurred in approximately half of the cases; and the substantia nigra was damaged in only 13% of these acute cases. We also found that after 1921, damage to cranial nerve nuclei was not reported. An analysis of the neuropathology and clinical symptoms revealed little correlation. CONCLUSIONS: Based on these findings, putative modern cases of acute EL with MRI/CT indicated lesions confined solely to the midbrain, brainstem, and/or basal ganglia should not be considered, consistent with that reported during epidemic period.


Asunto(s)
Encéfalo/patología , Brotes de Enfermedades/historia , Enfermedad de Parkinson Posencefalítica/epidemiología , Enfermedad de Parkinson Posencefalítica/patología , Adolescente , Adulto , Distribución por Edad , Anciano , Niño , Preescolar , Bases de Datos Factuales , Femenino , Historia del Siglo XX , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Enfermedad de Parkinson Posencefalítica/historia , Adulto Joven
4.
Anim Reprod Sci ; 102(3-4): 194-207, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17126505

RESUMEN

Severe fatty liver, a metabolic disease of dairy cows in early lactation, results in decreased health and reproductive performance, but can be alleviated by treatment with i.v. injections of glucagon. Mild fatty liver in cows effects on health and reproductive performance were determined by treatment with 14-day s.c. injections of glucagon at 7.5 or 15 mg/day. Multiparous Holstein cows (n=32) were grouped into Normal and Susceptible based on liver triacylglycerol concentrations (>1% liver tissue biopsy wet weight) at day 8 postpartum (day 0=day of parturition). Susceptible cows (n=24) were assigned randomly to three groups and s.c. injected with 0mg glucagon [60 ml 0.15M NaCl] [n=8] (same for Normal cows), 2.5 mg glucagon, or 5 mg glucagon every 8 h for 14 days, beginning day 8 postpartum. Mild fatty liver resulted in an increased number of days with elevated body temperature during the injection period, an increased incidence of mastitis after glucagon treatment, increased days to first estrus and insemination, increased days before conception occurred, and decreased conception rate. In cows with mild fatty liver, glucagon (15 mg/day) decreased the number of days with elevated body temperature and the incidence of mastitis after hormone treatment. From these results, we suggest that mild fatty liver is detrimental to health and reproduction of dairy cows and, furthermore, that exogenous glucagon decreases some of these detrimental effects.


Asunto(s)
Enfermedades de los Bovinos/tratamiento farmacológico , Hígado Graso/veterinaria , Glucagón/administración & dosificación , Lactancia , Reproducción/efectos de los fármacos , Animales , Bovinos , Enfermedades de los Bovinos/fisiopatología , Hígado Graso/tratamiento farmacológico , Hígado Graso/fisiopatología , Femenino , Estado de Salud , Inyecciones Subcutáneas , Mastitis Bovina/epidemiología , Mastitis Bovina/prevención & control , Periodo Posparto , Embarazo
5.
Poult Sci ; 85(10): 1795-7, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17012171

RESUMEN

Based on evidence from rodent models, it was hypothesized that furan fatty acids found in corn would inhibit reproduction in the laying hen. An isomeric mixture of furan fatty acids [9, (12)-oxy-10,13-dihydroxystearic acid and 10, (13)-oxy-9,12-dihydroxystearic acid] was administered for a period of 3 wk via the diet (1 and 3 ppm) at levels greater than those in corn to 20-wk-old pullets. There were no overt indications of acute or chronic toxicity (no effects on mortality, feed intake, or average daily gain). Similarly, there was no dose-dependent effect on reproductive parameters [egg production, egg weight, shell thickness, ovarian weight, number or weight of large yolky preovulatory follicles, and number of small yellow follicles (4-8 mm in diameter)]. The present data do not suggest that furan fatty acids are a cause of concern to the poultry industry.


Asunto(s)
Pollos/fisiología , Ácidos Grasos/química , Ácidos Grasos/toxicidad , Reproducción/efectos de los fármacos , Ácidos Esteáricos/química , Ácidos Esteáricos/toxicidad , Zea mays/química , Alimentación Animal , Animales , Peso Corporal , Dieta/veterinaria , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Ácidos Grasos/administración & dosificación , Femenino , Tamaño de los Órganos , Ovario/anatomía & histología , Ovario/efectos de los fármacos , Oviposición/efectos de los fármacos , Reproducción/fisiología , Ácidos Esteáricos/administración & dosificación
6.
Poult Sci ; 85(11): 1885-9, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17032818

RESUMEN

Isoflavones are soy compounds that possess weak estrogenic and antiestrogenic activities. In addition, phytochemicals, including isoflavones, may play a role in regulating seasonal reproductive cycles. As soy is a common constituent in poultry diets, the effect of these compounds on the reproductive system of production birds may be of concern. The present study examined the putative effects of soy isoflavones supplemented into the diet at 1 and 5% using endpoints of growth and reproduction in the Japanese quail. Isoflavones did not exert an effect on growth, feed intake, growth:feed, or the weight of the estrogen-sensitive immature oviduct in female quail. Furthermore, isoflavones did not influence the growth of the oviduct stimulated by exogenous estradiol. Similarly, isoflavones did not influence growth, feed intake, or growth:feed in male quail. However, isoflavones at 1%, but not 5%, in the diet reduced photoperiod-induced testis development 40% vs. control. In contrast, isoflavones did not influence testis regression stimulated by exogenous estradiol in sexually maturing male quail. The present results suggest that isoflavones may exert modest endocrine disruptor-like effects on reproduction in male, but not female, quail.


Asunto(s)
Coturnix/crecimiento & desarrollo , Isoflavonas , Fitoestrógenos/farmacología , Reproducción/efectos de los fármacos , Testículo/efectos de los fármacos , Alimentación Animal , Animales , Relación Dosis-Respuesta a Droga , Femenino , Isoflavonas/administración & dosificación , Isoflavonas/farmacología , Masculino , Oviductos/efectos de los fármacos , Oviductos/crecimiento & desarrollo , Fotoperiodo , Fitoestrógenos/administración & dosificación , Reproducción/fisiología , Factores Sexuales , Maduración Sexual/efectos de los fármacos , Maduración Sexual/fisiología , Testículo/crecimiento & desarrollo , Aumento de Peso/efectos de los fármacos
8.
J Cell Mol Med ; 10(1): 126-31, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16563225

RESUMEN

The release of neurotransmitters at the nerve terminal for neurotransmission, release of insulin from beta-cells of the endocrine pancreas for regulating blood glucose levels, the release of growth hormone from GH cells of the pituitary gland to regulate body growth, or the expulsion of zymogen from exocrine pancreas to digest food, are only a few examples of key physiological processes made possible by cell secretion. It comes as no surprise that defects in cell secretion are the cause for numerous diseases, and have been under intense investigation for over half century. Only in the last decade, the molecular machinery and mechanism of cell secretion has become clear. Cell secretion involves the docking and transient fusion of membrane-bound secretory vesicles at the base of plasma membrane structures called porosomes, and the regulated expulsion of intravesicular contents to the outside, by vesicle swelling. The discovery of the porosome in live cells, its morphology and dynamics at nanometer resolution and in real time, its isolation, its composition, and its structural and functional reconstitution in lipid membrane, are complete. The molecular mechanism of secretory vesicle fusion at the base of porosomes, and the regulated expulsion of intravesicular contents during cell secretion, are also resolved. In this minireview, the monumental discovery of the porosome, a new cellular structure at the cell plasma membrane, is briefly discussed.


Asunto(s)
Proteínas de Dominio MADS/genética , Proteínas de Dominio MADS/metabolismo , Factores Reguladores Miogénicos/genética , Factores Reguladores Miogénicos/metabolismo , Proteínas Inhibidoras de STAT Activados/metabolismo , Transcripción Genética , Activación Transcripcional , Secuencia de Aminoácidos , Animales , Diferenciación Celular , Secuencia de Consenso , Lisina/química , Factores de Transcripción MEF2 , Ratones , Datos de Secuencia Molecular , Mutación , Proteína SUMO-1/metabolismo , Homología de Secuencia de Aminoácido , Transfección , Ubiquitina-Proteína Ligasas/metabolismo
9.
Chemosphere ; 65(4): 674-81, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16516945

RESUMEN

The widely used herbicide, atrazine, has been reported to exhibit reproductive toxicity in rats and amphibians. The present studies investigate toxicity of atrazine in Japanese quail and its ability to influence reproduction in sexually immature females. Atrazine was administered in the diet at concentrations from 0.001 to 1000 ppm (approximately 109 mg kg-1 per day) or systemically via daily subcutaneous injections (1 and 10 mg kg-1) or Silastic implants. Atrazine did not cause overt toxicity in sexually immature female quail (no effects on change in body weight, feed intake, mortality or on circulating concentrations of the stress hormone, corticosterone). It was hypothesized that if atrazine were to have estrogenic activity or to enhance endogenous estrogen production, there would be marked increases in the weights of estrogen sensitive tissues including the oviduct, the liver and the ovary together with changes in gonadotropin secretion. However, atrazine had no effect on either liver or ovary weights. Atrazine in the diet increased oviduct weights at 0.1 and 1 ppm in some studies. These effects were not consistently observed and were not significant when data from studies were combined. Systemic administration of atrazine had no effect on oviduct weights. Dietary (concentrations from 0.001 to 1000 ppm) and systemically administered atrazine had no effect on circulating concentrations of luteinizing hormone (LH). The present studies provide evidence for a lack of general or reproductive toxicity of atrazine in birds.


Asunto(s)
Atrazina/toxicidad , Corticosterona/sangre , Coturnix , Disruptores Endocrinos/toxicidad , Estrógenos/metabolismo , Maduración Sexual/efectos de los fármacos , Administración Oral , Alimentación Animal , Animales , Peso Corporal/efectos de los fármacos , Coturnix/sangre , Coturnix/crecimiento & desarrollo , Coturnix/metabolismo , Femenino , Tamaño de los Órganos/efectos de los fármacos , Especificidad de Órganos
10.
Arch Environ Contam Toxicol ; 51(1): 117-22, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16418894

RESUMEN

The triazine herbicide, atrazine, has come under scrutiny for its reported feminizing effects in amphibians. To date, there is little information concerning the effects of atrazine on reproduction in avian species. The current study examined the putative reproductive toxicity of atrazine after exposure in ovo. Atrazine at 504, 246, and 123 microg/kg was administered to Japanese quail eggs before incubation. The eggs were hatched and the birds raised to 14 days of age. Indices of hatchability, sex ratios, and growth were determined. Furthermore, circulating concentrations of reproductive hormones (estradiol, progesterone, and testosterone) and gonadal histology were examined. Atrazine at 504 microg/kg decreased 14-day hatchling weight by 13.1% versus controls. However, no detrimental effects on hatchability or sex ratios were observed. In female birds, atrazine at 504 microg/kg decreased ovarian weights and circulating concentrations of progesterone to 48.3% and 73.3%, respectively, versus control. However, concentrations of estradiol and testosterone did not differ from controls. In male quail, at all doses tested, atrazine had no effect on gonadal weights or circulating concentrations of estradiol, testosterone, or progesterone. Moreover, no incidences of left ovotestis formation were observed. In contrast, 10 ng/kg ethinylestradiol (a positive control) induced the formation of a left ovotestis in four of eight birds analyzed. The current results may suggest that exposure to atrazine in ovo at concentrations above ecologic relevance exerts effects on the reproductive system of young Japanese quail. However, no evidence is presented that atrazine induces feminization of the testis in male quail.


Asunto(s)
Atrazina/toxicidad , Coturnix/embriología , Herbicidas/toxicidad , Animales , Coturnix/sangre , Desarrollo Embrionario/efectos de los fármacos , Estradiol/sangre , Femenino , Masculino , Tamaño de los Órganos/efectos de los fármacos , Ovario/efectos de los fármacos , Ovario/crecimiento & desarrollo , Progesterona/sangre , Testículo/efectos de los fármacos , Testículo/crecimiento & desarrollo , Testosterona/sangre
11.
Domest Anim Endocrinol ; 29(1): 111-44, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15927771

RESUMEN

Growth hormone (GH) released from pituitary under direct control of hypothalamic releasing (i.e., GHRH) and inhibiting (i.e., sst or SRIF) hormones is an anabolic hormone that regulates metabolism of proteins, fats, sugars and minerals in mammals. Cyril Bowers' discovery of GH-releasing peptide (GHRP-6) was followed by a search for synthetic peptide and nonpeptide GH-secretagogues (GHSs) that stimulate GH release, as well as a receptor(s) unique from GHRH receptor. GHRH and GHSs operate through distinct G protein-coupled receptors to release GH. Signal transduction pathways activated by GHS increase intracellular Ca2+ concentration in somatotrophs, whereas GHRH increases cAMP. Isolation and characterization of ghrelin, the natural ligand for GHS receptor, has opened a new era of understanding to physiology of anabolism, feeding behavior, and nutritional homeostasis for GH secretion and gastrointestinal motility through gut-brain interactions. Other peptide hormones (i.e., motilin, TRH, PACAP, GnRH, leptin, FMRF amide, galanin, NPY, NPW) from gut, brain and other tissues also play a role in modulating GH secretion in livestock and lower vertebrate species. Physiological processes, such as neurotransmission, and secretion of hormones or enzymes, require fusion of secretory vesicles at the cell plasma membrane and expulsion of vesicular contents. This process for GH release from porcine somatotrophs was revealed by atomic force microscopy (AFM), transmission electron microscopy (TEM) and immunohistochemical distribution of the cells in pituitary during stages of development.


Asunto(s)
Hormonas Peptídicas/fisiología , Secuencia de Aminoácidos , Animales , Benzazepinas/farmacología , Ghrelina , Hormona del Crecimiento/metabolismo , Hormona Liberadora de Hormona del Crecimiento , Humanos , Datos de Secuencia Molecular , Sistemas Neurosecretores/fisiología , Hormonas Peptídicas/química , Tetrazoles/farmacología
12.
Domest Anim Endocrinol ; 29(1): 23-33, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15905067

RESUMEN

There has been extensive research of the anterior pituitary gland of livestock and poultry due to the economic (agricultural) importance of physiological processes controlled by it including reproduction, growth, lactation and stress. Moreover, farm animals can be biomedical models or useful in evolutionary/ecological research. There are for multiple sites of control of the secretion of anterior pituitary hormones. These include the potential for independent control of proliferation, differentiation, de-differentiation and/or inter-conversion cell death, expression and translation, post-translational modification (potentially generating multiple isoforms with potentially different biological activities), release with or without a specific binding protein and intra-cellular catabolism (proteolysis) of pituitary hormones. Multiple hypothalamic hypophysiotropic peptides (which may also be produced peripherally, e.g. ghrelin) influence the secretion of the anterior pituitary hormones. There is also feedback for hormones from the target endocrine glands. These control mechanisms show broadly a consistency across species and life stages; however, there are some marked differences. Examples from growth hormone, prolactin, follicle stimulating hormone and luteinizing hormone will be considered. In addition, attention will be focused on areas that have been neglected including the role of stellate cells, multiple sub-types of the major adenohypophyseal cells, functional zonation within the anterior pituitary and the role of multiple secretagogues for single hormones.


Asunto(s)
Animales Domésticos/fisiología , Adenohipófisis/fisiología , Animales , Modelos Animales , Adenohipófisis/citología , Hormonas Adenohipofisarias/biosíntesis , Hormonas Adenohipofisarias/metabolismo , Isoformas de Proteínas , Investigación
13.
Domest Anim Endocrinol ; 26(1): 75-86, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14732454

RESUMEN

The melanocortin-4 receptor (MC4R), a G protein-coupled seven-transmembrane receptor, which is expressed in the brain, plays an important role in the control of mammalian energy homeostasis. A missense mutation (Asp298Asn) was identified in the porcine MC4R gene, which is associated with growth and food intake traits. The Asn298 mutation occurs within a highly conserved motif, NPLIY, of all members of G protein-coupled receptors; whereas, Asp298 is conserved in all five melanocortin receptor subtypes. Functional analysis of the porcine MC4R variant was performed with an in vitro gene expression system in 293 cells. Ligand binding (NDP-alphaMSH) did not differ between Asp298 and Asn298 MC4R proteins. However, the Asn298 MC4R variant was unable to stimulate cAMP production in response to NDP-alphaMSH stimulation; whereas, the Asp298 variant could stimulate cAMP accumulation. These results demonstrate that the Asp298 is required for normal MC4R signaling to the adenylyl cyclase. Sequencing of the MC4R gene of seven diverse genera within the Suiformes that include Hippopotamidae (hippos), Tayassuidae (peccaries) and Suidae (pigs), revealed 62 nucleotide variations in MC4R. Phylogenetic relationships of MC4R variations are consistent with those previously described from morphological and physiological data among the subfamilies of the Suiformes. These findings revealed that a single missense mutation (Asp298Asn) of aspartic acid (Asp) to asparagine (Asn) in MC4R gene decreased cAMP content and MC4R signaling, but with no difference in the ligand binding was associated with growth and feed intake traits in domestic pigs.


Asunto(s)
Mutación Missense , Receptor de Melanocortina Tipo 4/genética , Porcinos/genética , Adenilil Ciclasas/fisiología , Animales , Secuencia de Bases , Línea Celular , Clonación Molecular , AMP Cíclico/fisiología , Evolución Molecular , Datos de Secuencia Molecular , Filogenia , Receptor de Melanocortina Tipo 4/fisiología , Análisis de Secuencia de ADN , Porcinos/fisiología , alfa-MSH/fisiología
14.
J Endocrinol ; 175(3): 625-36, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12475374

RESUMEN

The effects of a GH secretagogue, L-692,585 (L-585), and human GH-releasing hormone (hGHRH) on calcium transient and GH release were investigated in isolated porcine pituitary cells using calcium imaging and the reverse hemolytic plaque assay (RHPA). Somatotropes were functionally identified by the application of hGHRH. All cells that responded to hGHRH responded to L-585 application. Perfusion application of 10 microM hGHRH and L-585 for 2 min resulted in an increase in intracellular calcium concentrations ([Ca(2+)](i)) of 53+/-1 nM (mean+/-S.E.M.) (P < 0.01) and 68+/-2 nM (P < 0.01) respectively. The L-585 response was characterized by an initial increase in [Ca(2+)](i) followed by a decline to a plateau level above the baseline. Concurrent calcium imaging with RHPA indicated that the L-585-evoked increase in [Ca(2+)](i) coincided with GH release. L-585 significantly increased the percentage of plaque-forming cells (24+/-3 vs 40+/-6%; P < 0.05) and mean area of plaques (1892+/-177 vs 3641+/-189 micro m(2); P < 0.01) indicating increased GH release. Substance P (SP) analogue ([d -Arg(1),d -Phe(5),d -Trp(7,11)]-SP) blocked, and the hGHRH receptor antagonist ((Phenylac-Tyr(1),d -Arg(2), p-chloro-Phe(6), Homoarg(9), Tyr (Me)(10), Abu(15), Nle(27),d -Arg(28), Homoarg(29))-GRF (1-29) amide) decreased the stimulatory effect of hGHRH. These failed to block the stimulatory effect of L-585, suggesting a different receptor for L-585 from the GHRH receptor. The hGHRH-induced calcium transients and initial peak increase induced by L-585 were significantly decreased by removal of calcium from the bathing medium or the addition of nifedipine, an L-calcium channel blocker. The plateau component of L-585-induced calcium change was abolished by removal of calcium and nifedipine. These results suggest an involvement of calcium channels in GH release. Either SQ-22536, an adenylate cyclase inhibitor, or U73122, a phospholipase C (PLC) inhibitor, blocked the stimulatory effects of hGHRH and L-585 on [Ca(2+)](i) transient, indicating the involvement of adenylate cyclase-cAMP and PLC-inositol triphosphate pathways. These results further suggested that calcium mobilization from internal stores during the first phase of the L-585 response induced an increase in [Ca(2+)](i) whereas calcium influx during the second phase is a consequence of somatotrope depolarization.


Asunto(s)
Adenina/análogos & derivados , Benzazepinas/farmacología , Calcio/metabolismo , Hormona del Crecimiento/metabolismo , Hipófisis/metabolismo , Tetrazoles/farmacología , Adenina/farmacología , Inhibidores de Adenilato Ciclasa , Animales , Células Cultivadas , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/farmacología , Estrenos/farmacología , Hormona Liberadora de Hormona del Crecimiento/farmacología , Técnica de Placa Hemolítica , Humanos , Procesamiento de Imagen Asistido por Computador , Microscopía Fluorescente , Perfusión , Hipófisis/efectos de los fármacos , Pirrolidinonas/farmacología , Estimulación Química , Porcinos , Fosfolipasas de Tipo C/antagonistas & inhibidores
15.
Acta Neuropathol ; 103(1): 66-73, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11841033

RESUMEN

Human perinatal hypoxic-ischemic brain injury is an important cause of death and morbidity. One relatively common pattern of perinatal injury involves selective neuronal death in the ventral gray matter of the pons and in the subiculum of the hippocampal formation, classically termed 'pontosubicular neuronal necrosis' (PSN). The vulnerable neurons undergo karyorrhectic condensation of their nuclear chromatin and exhibit in situ end labeling for DNA fragmentation, leading to the recent reclassification of cell death in PSN as apoptotic. Caspase activation plays a central role in apoptosis and caspase-3 appears to be an especially important effector enzyme in neuronal apoptosis. In this study we performed immunohistochemistry on brain sections from six postmortem cases of PSN using two polyclonal antisera; CM1, a specific marker of caspase-3 activation, and fractin, which specifically recognizes a neoepitope at a caspase cleavage site in actin, and is therefore a marker of caspase-like proteolytic activity. Numerous CM1- and fractin-immunolabeled neurons were seen in the nuclei pontis and subiculum in each case, and the great majority showed karyorrhectic morphology. The immunostaining involved the nuclei and cytoplasm of these cells and the proximal portions at least of their neuritic processes. Some neurons exhibited a more extensive pattern of dendritic fractin labeling. Frequent CM1- and fractin-immunoreactive axonal segments were also seen. The identification of caspase-3 activation and caspase-like proteolytic activity in PSN cases in this study suggests that caspase inhibitors may potentially have a therapeutic neuroprotective role in human perinatal hypoxic-ischemic brain injury.


Asunto(s)
Asfixia Neonatal/metabolismo , Asfixia Neonatal/patología , Caspasas/metabolismo , Hipoxia-Isquemia Encefálica/metabolismo , Hipoxia-Isquemia Encefálica/patología , Actinas/análisis , Actinas/metabolismo , Apoptosis , Caspasa 3 , Femenino , Humanos , Inmunohistoquímica , Recién Nacido , Masculino , Neuronas/química , Neuronas/enzimología , Neuronas/patología , Puente/química , Puente/enzimología , Puente/patología
16.
Anim Reprod Sci ; 69(3-4): 223-37, 2002 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-11812632

RESUMEN

Chinese Meishan pigs develop rapidly with onset of puberty at less than 100 days of age, and have a smaller placental size and larger litter size as compared with British/Continental breeds. POU1F1 is a member of the POU-domain family gene and is a positive regulator for growth hormone (GH), prolactin (PRL), and thyroid-stimulating hormone beta (TSHbeta) in several mammalian species. To investigate the role of POU1F1 in controlling pig growth and reproduction traits, Meishan (MS) pigs segregating a MspI POU1F1 polymorphism were used to determine differences of GH and PRL at both mRNA and circulating hormone concentrations. Animals from nine litters were used to collect pituitary (n=60) and/or blood samples (n=80) at day 0, 15, and 30 after birth, and all animals were genotyped (CC, CD, DD) for the MspI POU1F1 polymorphism. Reverse transcriptase-polymerase chain reaction (RT-PCR) with standard curve quantification was used to quantify mRNA levels for GH, PRL, and two alternative POU1F1 transcripts, POU1F1-alpha, and POU1F1-beta. Radioimmunoassays were done to determine the circulating concentration of GH and PRL in blood plasma. Our results indicated a significant effect of POU1F1 genotype on circulating levels of both GH and PRL at birth, but not thereafter. The DD neonates had lower levels of GH, but higher levels of PRL, than other genotypes. POU1F1-alpha mRNA decreased (P<0.05) from days 0 to 30, which paralleled decreases (P<0.05) in GH mRNA as well as PRL and GH plasma levels over the same period. POU1F1-beta mRNA levels did not significantly change over this period. Correlations were significant between POU1F1-alpha mRNA and both GH mRNA and GH plasma concentration levels, as well as between the two POU1F1 mRNA isoforms. Results from this study add to our understanding of the role of POU1F1 in controlling pig development and reproduction.


Asunto(s)
Hormona del Crecimiento/sangre , Prolactina/sangre , Porcinos/genética , Factores de Transcripción/genética , Envejecimiento/fisiología , Animales , Animales Recién Nacidos , Femenino , Genotipo , Hormona del Crecimiento/genética , Tamaño de la Camada , Masculino , Polimorfismo Genético , Prolactina/genética , ARN Mensajero/análisis , Radioinmunoensayo/veterinaria , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/veterinaria , Porcinos/sangre , Porcinos/crecimiento & desarrollo , Tirotropina , Factores de Tiempo , Factores de Transcripción/fisiología
18.
Biol Reprod ; 65(1): 295-300, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11420252

RESUMEN

We tested the hypotheses that 1) epidural anesthesia at parturition would block both peripheral and central release of oxytocin and eliminate the development of maternal behavior in primiparous heifers and 2) estradiol priming, genital stimulation, and appropriate neonatal stimuli would induce maternal behavior in nulliparous heifers. In experiment 1, primiparous crossbred heifers (n = 13) with cannulas in the third cerebroventricle (IIIV) were assigned randomly to receive epidural treatments of saline (SAL; n = 6) or lidocaine HCl (EPI; n = 7) at the onset of labor induced between Days 270 and 280 of gestation. Epidural anesthesia blocked (P < 0.001) both central and peripheral release of oxytocin and markedly reduced (P < 0.05) or eliminated licking behaviors during a 3-h period following parturition as compared with SAL. Following approximately 1 wk of controlled daily suckling, during which calves were permitted access only to the inguinal region of their dams (three times daily for 10 min each time), a second maternal behavior test was performed. Although licking behavior remained markedly reduced (P < 0.001) in the EPI compared with the SAL groups, all heifers accepted their calf at the udder. In experiments 2-4, neither estradiol priming in ovariectomized heifers nor estradiol plus progesterone in intact heifers resulted in an induction of maternal behaviors following genital stimulation and presentation of a neonate wetted with amniotic fluid. Pelvic sensory deficits apparently block oxytocin release and disturb both short-latency and long-term maternal behaviors but do not result ultimately in rejection of the calf. Combinations of hormonal, sensory, olfactory, and visual cues observed previously to induce maternal behavior in nulliparous ewes do not appear adequate for induction of maternal behavior in nulliparous heifers.


Asunto(s)
Química Encefálica/fisiología , Genitales Femeninos/fisiología , Conducta Materna/fisiología , Ovario/metabolismo , Oxitocina/metabolismo , Esteroides/metabolismo , Animales , Bovinos , Estradiol/sangre , Estradiol/farmacología , Femenino , Ovariectomía , Oxitocina/sangre , Oxitocina/líquido cefalorraquídeo , Estimulación Física , Embarazo , Progesterona/sangre , Progesterona/farmacología , Transducción de Señal/fisiología
19.
Domest Anim Endocrinol ; 20(2): 89-100, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11311847

RESUMEN

The objective was to test the hypothesis that dopamine regulates prolactin (PRL) secretion by determining acute changes in catecholamine concentrations in hypophyseal portal blood of cattle, and their relation to peripheral blood concentration of PRL in hypophyseal stalk-transected (HST) and sham-operated controls (SOC). Holstein heifers (606 +/- 21 kg BW; mean +/- SE) were subjected to neurosurgery for 8 h to collect hypophyseal portal blood with a stainless steel cannula designed with a cuff placed under the pituitary stalk and peripheral blood via a jugular vein catheter. PRL plasma concentration was measured by radioimmunoassay, and dopamine and norepinephrine in portal plasma by radioenzymatic assay. During anesthesia before HST or SOC, PRL plasma concentration ranged from 20-40 ng/ml throughout 255 min. PRL abruptly increased and remained above 90 ng/ml after HST compared with a steady decrease to <20 ng/ml in SOC heifers throughout 440 min. Within 5 min after severing the hypophyseal stalk, dopamine in portal blood (>8 ng/ml) was significantly increased (P < 0.05) compared with peripheral blood (<2 ng/ml). Norepinephrine concentration in portal blood was significantly greater (P < 0.05) than in peripheral blood during the first 60 min. The sustained high PRL level in peripheral plasma after severing the hypophyseal stalk stimulated hypothalamic dopamine secretion from hypophyseal portal vessels during the prolonged period of blood collection. Norepinephrine concentration in these cattle was greater in hypophyseal portal than in peripheral blood, implicating both an important hypothalamic source of the catecholamine as well as an adrenal gland contribution during anesthesia.


Asunto(s)
Bovinos/fisiología , Dopamina/metabolismo , Norepinefrina/metabolismo , Hipófisis/irrigación sanguínea , Prolactina/sangre , Animales , Dopamina/sangre , Femenino , Cinética , Norepinefrina/sangre , Hipófisis/fisiología , Hipófisis/cirugía , Sistema Porta
20.
Anim Reprod Sci ; 63(3-4): 255-74, 2000 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-10989235

RESUMEN

The objectives were to determine hypothalamic regulation of pulsatile luteinizing hormone (LH) secretion in female pigs and the biphasic feedback actions of estradiol-17beta (E(2)-17beta). In the first study, the minimum effective dosage of E(2)-17beta that would induce estrus in ovariectomized gilts was determined to be 20microg/kg body weight. In the second study, ovariectomized gilts were assigned randomly on day 0 to treatments: (a) hypophyseal stalk transection (HST), (b) cranial sham-operated control (SOC), and (c) unoperated control (UOC). On day 3, gilts from each group received a single i.m. injection of either E(2)-17beta (20microg/kg body weight) or sesame oil. Blood was collected from an indwelling jugular cannula at 15min intervals for 3h before (day -2) and after treatment (day 2) from HST, SOC and UOC gilts. On day 3, blood was collected at 2h intervals for 12h after E(2)-17beta or sesame oil injection and at 4h intervals thereafter for 108h. Pulsatile LH secretion in all gilts 2 days after ovariectomy exhibited a frequency of 0.9+/-0.06peaks/h, amplitude of 1.3+/-0.13ng/ml, baseline of 0.8+/-0.07. Serum LH concentrations from SOC and UOC gilts were similar on day 2 and profiles did not differ from those on day -2. In HST gilts pulsatile LH release was abolished and mean LH concentration decreased compared with controls (0 versus 0.9+/-0. 06peaks/h and 0.77+/-0.03 versus 1.07+/-0.07ng/ml, respectively; P<0. 05). E(2)-17beta or sesame oil did not affect serum LH concentration in HST gilts, and LH remained constant throughout 120h (0.7+/-0. 07ng/ml). In SOC and UOC control gilts, E(2)-17beta induced a 60% decrease (P<0.05) in LH concentration within 12h, and LH remained low until 48h, then increased to peak values (P<0.05) by 72h, followed by a gradual decline to 120h. Although pituitary weight decreased 31% in HST gilts compared with controls (228 versus 332mg, P<0.05), an abundance of normal basophils was evident in coronal sections of the adenohypophysis of HST comparable to that seen in control gilts. The third and fourth studies determined that hourly i. v. infusions of LHRH (2microg) and a second injection of E(2)-17beta 48h after the first had no effect on the positive feedback action of estrogen in UOC. However, in HST gilts that received LHRH hourly, the first injection of E(2)-17beta decreased (P<0.05) plasma LH concentrations while the second injection of E(2)-17beta failed to induce a positive response to estrogen. These results indicate that both pulsatile LH secretion and the biphasic feedback action of E(2)-17beta on LH secretion depend on hypothalamic regulatory mechanisms in the gilts. The isolated pituitary of HST gilts is capable of autonomous secretion of LH; E(2)-17beta will elicit direct negative feedback action on the isolated pituitary gland if the gonadotropes are supported by exogenous LHRH, but E(2)-17beta at high concentrations will not induce positive feedback in isolated pituitaries. Thus, the direct effect of E(2)-17beta on the pituitary of monkeys cannot be mimicked in pigs.


Asunto(s)
Estradiol/farmacología , Hormona Luteinizante/metabolismo , Hipófisis/fisiología , Porcinos/fisiología , Animales , Femenino , Hormona Liberadora de Gonadotropina/farmacología , Hipotálamo/efectos de los fármacos , Hipotálamo/fisiología , Ovariectomía , Hipófisis/efectos de los fármacos , Flujo Pulsátil , Aceite de Sésamo/farmacología , Glándula Tiroides/efectos de los fármacos , Glándula Tiroides/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA